Continuous Processing for Production of Biopharmaceutical Products
This intensive professional development course delivers a comprehensive blueprint for designing, integrating, and operating next-generation continuous bioprocesses. Whether you are looking to optimize an existing workflow or build a facility from the ground up, this course bridges cutting-edge theory with practical, real-world application.
| Dates | Course | Cost | Registration |
|---|---|---|---|
| May 12-13, 2026 | Artificial Intelligence in FDA-Regulated Manufacturing: From Foundations to Implementation | $1,500 (2026 registration closed) | |
| May 20–21, 2026 | Hands-On Essentials of Automation for Biomanufacturing | $2,050 (2026 registration closed) | |
| May 27–29, 2026 | Preparative Chromatography Column Packing: Lab to Process Scale | $2,500 | |
| June 3–4, 2026 | Applied Cleaning Validation Practices: A STERIS Master Class | $2,000 (2026 registration closed) | |
| June 9–10, 2026 | Introduction to Biopharmaceutical Lyophilization | $1,975 (2026 registration closed) | |
| June 11, 2026 | Essentials of Spray Drying and Powder Analysis | $995 (2026 registration closed) | |
| June 16–18, 2026 | Fundamentals of Mammalian Cell Line Development | $3,100 (2026 registration closed) | |
| June 23–25, 2026 | Biopharmaceutical Assay Essentials | $3,100 | Register |
| June 23–25, 2026 | Fermentation Engineering | $3,100 | Register |
| June 30–July 2, 2026 | Hands-On Principles of mRNA Technology | $2,500 (2026 registration closed) | |
| July 8–10, 2026 | Downstream Biopharmaceutical Processes: Fundamentals and Design | $3,100 | Register |
| July 14–16, 2026 | AAV Quality Attributes: Theory and Practice | $2,975 | Register |
| July 14–17, 2026 | Hands-On cGMP Biomanufacturing Operations | $4,200 | Register |
| July 28–31, 2026 | Hands-On Biomanufacturing of Vectors for Gene Therapy | $4,500 | Register |
| Aug 6, 2026 | Design of Experiments for Biomanufacturing | $500* | Register |
| Sept 29–Oct 1, 2026 | Cell Culture Engineering | $4,200 | Register |
| Oct 9, 2026 | Distributed Control Systems for Bioprocessing Operators | $775 | Register |
| Oct 13–16, 2026 | Applied Principles and Techniques of Depth Flow Filtration (DFF) and Tangential Flow Filtration (TFF) for BioPharm Purification | $3,995 | Register |
| Oct 28-29, 2026 | Continuous Processing for Production of Biopharmaceutical Products | $995 | Register |
| Nov 10–12, 2026 | PAT for Real-time Culture Monitoring and Closed-Loop Process Control | $2,975 | Register |
| TBD | Microbial Contamination Control in Bioprocessing Operations | $2,975 |
Register by October 13
Attend and you will
- Understand the basics of process design, process monitoring and process control
- Be able to plan and perform required experiments for designing key unit operations of mammalian cell culture, process chromatography and ultrafiltration/ diafiltration
- Be capable of performing process integration to create end-to-end process platforms
- Gain familiarity over concepts of process modeling and its role in process optimization, monitoring and control
- Understand the role of analytical methodologies in successful execution of continuous process platforms
- Become well informed of the various challenges that need to be successful addressed during creation of these platforms
Delivery methods
75% Lecture
25% Discussion/group activity
Course content
50% Fundamentals and concepts
30% Industry applications
20% Emerging technologies
15 hours of instruction
What makes this course different
Case studies will be presented to gain a deeper understanding of these topics:
- Hardware for enabling continuous processing
- Continuous flow operations (e.g. viral inactivation)
- Continuous chromatography
- Continuous UF DF
- Process integration
- End-to-end process platforms (microbial and mammalian)
- Surge tank management
- Process monitoring and control
- Process economics
Who should attend
Scientists and engineers that are involved in design and execution of continuous manufacturing of biopharmaceutical products.
Instructors
Anurag S. Rathore, Ph.D.
Professor, Department of Chemical Engineering
Indian Institute of Technology, Delhi
Anurag S. Rathore is an Institute Chair Professor at the Department of Chemical Engineering, Indian Institute of Technology, Delhi, India. He is also the Coordinator for the DBT COE for Biopharmaceutical Technology. His previous roles included management positions at Amgen Inc., Thousand Oaks, California and Pharmacia Corp., St. Louis, Missouri. His areas of interest include process development, scale-up, technology transfer, process validation, biosimilars, continuous processing, formulation, biopharmaceutics, PAT and QbD. He has authored more than 800 publications and presentations in these areas. Prof. Rathore has been a recipient of the Tata Transformation Prize 2023 and Agilent Thought Leader Award 2020. He is presently serving as the Editor-in-Chief of The AAPS Journal and Associate Editor for Journal of Chemical Technology and Biotechnology. He also serves on the Editorial Advisory Boards for Biotechnology Progress, Biotechnology Journal, Electrophoresis, BioPharm International, Journal of Chromatography B, Journal of Chromatography Open, Pharmaceutical Technology Europe, and Separation and Purification Reviews. Dr. Rathore has edited books titled Process Validation (2023), Preparative Chromatography for Separation of Proteins and Peptides (2017), Quality by Design for Biopharmaceuticals: Perspectives and Case Studies (2009), Elements of Biopharmaceutical Production (2007), Process Validation (2005), Electrokinetic Phenomena (2004), and Scale-up and Optimization in Preparative Chromatography (2003). He has a Ph.D. in Chemical Engineering from Yale University.
Mark Schofield
Director, Cytiva
Mark Schofield leads a team of scientists and engineers to fundamentally understand how separations work and apply that knowledge to challenging purifications. He is happiest guiding technology and innovation through an understanding of applications. But more recently, has been driving thought leadership and building bridges to better serve science and the biopharmaceutical industry!